Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting.
about
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based RegimensEfficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature.Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir.Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.Improved adipose tissue function with initiation of protease inhibitor-only ART.Determinants of residual viraemia during combination HIV treatment: Impacts of baseline HIV RNA levels and treatment choice.Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations.High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
P2860
Q28550153-06ACF270-D87B-4903-A199-4156E5ABA9F4Q31034183-1DF96F65-6F1A-4BEE-AD68-0F3386B57BE1Q36426953-0B329A86-5676-4520-8275-353CBE58213CQ38170576-4B221EB6-1AA1-4063-8131-CFA50EA25EB7Q38222092-690FD761-A3BC-412C-9892-7D3982818E8EQ39178197-F5A869ED-3BD0-4471-8958-939FC5A6EAB9Q40578427-C3FD008B-DCDE-492D-AEC2-1BBC7236470DQ40922638-45581F6B-057A-41BE-A032-0FCA00FD5ACEQ50070825-7D4935CA-B176-43B9-ACF3-356C20AE1C77Q52591808-777BDD1E-BE24-4425-9B13-F7706E0059D4Q58713369-FE19E300-CAD1-4D05-982C-11881E934D1E
P2860
Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Boosted protease inhibitor mon ...... European expert panel meeting.
@ast
Boosted protease inhibitor mon ...... European expert panel meeting.
@en
type
label
Boosted protease inhibitor mon ...... European expert panel meeting.
@ast
Boosted protease inhibitor mon ...... European expert panel meeting.
@en
prefLabel
Boosted protease inhibitor mon ...... European expert panel meeting.
@ast
Boosted protease inhibitor mon ...... European expert panel meeting.
@en
P2860
P50
P356
P1476
Boosted protease inhibitor mon ...... European expert panel meeting.
@en
P2093
Dan Turner
Manuela Doroana
P2860
P2888
P356
10.1186/1742-6405-10-3
P577
2013-01-24T00:00:00Z
P5875
P6179
1013756617